Abstract |
The efficacy and safety of quetiapine fumurate in the treatment of patients with schizophrenia were evaluated in an 8-week, multicenter, open-label study. The results of this study which included a total of 54 patients showed good efficacy and safety profile for quetiapine fumarate as seen by the improvement rate (moderate or above in the final global improvement rating) of 49.1% and safety rate (no problem in overall safety rating) of 66.0%. The mean BPRS total score decreased significantly from 55.5 +/- 10.9 points at baseline to 45.4 +/- 13.0 points at the completion of administration. The PANSS scores also showed significant improvement on all scales; the mean scores decreased from 20.7 +/- 6.3 points at baseline to 17.7 +/- 6.9 points at withdrawal or completion of administration on the positive scale, from 27.8 +/- 5.8 points to 24.0 +/- 7.3 points on the negative scale, and from 51.4 +/- 10.1 points to 44.7 +/- 12.4 points on the general psychopathology scale. Although the most frequent adverse reactions were somnolence (18.9%), insomnia (17.0%), nervousness (13.2%), dizziness (13.2%), malaise (13.2%), postural hypotension (11.3%), tachycardia (9.4%), and constipation (9.4%), the incidence of extrapyramidal symptoms was low (11.3%). From these results, quetiapine fumarate was suggested to be highly effective and safe for the treatment of schizophrenia.
|
Authors | M Murasaki, T Yamauchi, G Yagi, T Nakajima, Y Nakane, Y Kudo |
Journal | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology
(Nihon Shinkei Seishin Yakurigaku Zasshi)
Vol. 19
Issue 2
Pg. 53-66
(Apr 1999)
ISSN: 1340-2544 [Print] Japan |
PMID | 10464776
(Publication Type: Clinical Trial, Clinical Trial, Phase II, English Abstract, Journal Article, Multicenter Study)
|
Chemical References |
- Antipsychotic Agents
- Dibenzothiazepines
- Quetiapine Fumarate
|
Topics |
- Adult
- Aged
- Antipsychotic Agents
(adverse effects, therapeutic use)
- Anxiety
(chemically induced)
- Dibenzothiazepines
(adverse effects, therapeutic use)
- Dizziness
(chemically induced)
- Female
- Humans
- Male
- Middle Aged
- Psychiatric Status Rating Scales
- Quetiapine Fumarate
- Schizophrenia
(diagnosis, drug therapy)
- Sleep Wake Disorders
(chemically induced)
- Treatment Outcome
|